Cite
HARVARD Citation
Dytfeld, D. et al. (n.d.). S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM-CELL TRANSPLANT FOR MULTIPLE MYELOMA. HemaSphere. pp. 76-77. [Online].